Brunswick Corp (NYSE: BC) grants director 562 deferred common shares

Rhea-AI Filing Summary

Brunswick Corp director Lauren Patricia Flaherty reported a grant of 562 deferred shares of common stock on July 31, 2026 at $79 per share. The deferred shares are held in a director deferred account and will be distributed in predetermined installments after she ceases serving as director.

Following this award, her direct beneficial holdings total 18,247 shares, including 91 shares acquired through dividend reinvestments through June 2026.

Insider Trade Summary

Net Buyer: 562 shares

Net Buy 1 txn

Insider FLAHERTY LAUREN PATRICIA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	562	$79.00	$44K

Holdings After Transaction: Common Stock — 18,247 shares (Direct)

Footnotes (2)

1. F1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
2. F2. Beneficial holdings include 91 shares acquired pursuant to dividend reinvestments through June 2026.

Key Figures

Deferred share award: 562 shares Award price: $79 per share Shares held after award: 18,247 shares +2 more

5 metrics

Deferred share award 562 shares Grant of deferred common stock to director on July 31, 2026

Award price $79 per share Per-share value reported for the 562-share deferred grant

Shares held after award 18,247 shares Total direct beneficial holdings following the reported transaction

Dividend reinvestment shares 91 shares Portion of beneficial holdings acquired via dividend reinvestments through June 2026

Transaction date July 31, 2026 Date of the deferred share grant to the director

Key Terms

deferred shares, deferred account, beneficial holdings, dividend reinvestments, +1 more

5 terms

deferred shares financial

"Deferred shares deposited in the director's deferred account"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

deferred account financial

"deposited in the director's deferred account, which will be automatically distributed"

beneficial holdings financial

"Beneficial holdings include 91 shares acquired pursuant to dividend reinvestments"

dividend reinvestments financial

"91 shares acquired pursuant to dividend reinvestments through June 2026"

predetermined installments financial

"which will be automatically distributed in predetermined installments after the director ceases"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/03/2026 - 06:18 PM Accepted by SEC EDGAR 08/03/2026 - 06:18 PM Learn about SEC filing dates

FAQ

What insider transaction did Brunswick Corp (BC) report for director Lauren Flaherty?

Brunswick Corp reported that director Lauren Patricia Flaherty received a grant of 562 deferred shares of common stock on July 31, 2026 at $79 per share, coded as a grant or award acquisition on a Form 4 filing.

How many Brunswick Corp (BC) shares does Lauren Flaherty hold after this Form 4 transaction?

After the reported grant, Lauren Flaherty’s beneficial holdings total 18,247 shares of Brunswick common stock. This total includes 91 shares that were acquired through dividend reinvestments through June 2026, as noted in the filing’s footnotes.

What is the nature of the deferred shares granted to the Brunswick Corp (BC) director?

The 562 shares are described as deferred shares deposited in the director’s deferred account. They will be automatically distributed in predetermined installments after she ceases being a director of Brunswick Corp, rather than being immediately deliverable.

Was the Brunswick Corp (BC) director’s share grant executed under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox as not affirmed, and no footnote states that this grant occurred under a trading plan. The transaction is coded as a grant or award acquisition rather than an open-market trade.

What price was used for the Brunswick Corp (BC) deferred share award to Lauren Flaherty?

The transaction reports a price of $79 per share for the 562 deferred shares of Brunswick common stock. This price is presented as a per-share value in the non-derivative transaction details of the Form 4.

How are dividend reinvestments reflected in Lauren Flaherty’s Brunswick Corp (BC) holdings?

A footnote explains that her beneficial holdings include 91 shares acquired through dividend reinvestments through June 2026. These reinvested dividends are part of the total 18,247 Brunswick common shares reported after the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLAHERTY LAUREN PATRICIA

(Last) (First) (Middle)

C/O BRUNSWICK CORPORATION

26125 N RIVERWOODS BLVD SUITE 500

(Street)

METTAWA ILLINOIS 60045

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2026		A		562(1)	A	$79	18,247(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

2. Beneficial holdings include 91 shares acquired pursuant to dividend reinvestments through June 2026.

Remarks:

	By: Power of Attorney For: /s/ Lauren Patricia Flaherty	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)